<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2706222269
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2008
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DOLVIC- K 50 MG F- C TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC POTASSIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        11.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Med city" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Med city
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Med City Pharma
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Diclofenac potassium, the active ingredient in <strong>Dolvic-K</strong><strong><sup>&reg;</sup></strong> tablets, is one of a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs reduce pain and inflammation.</p><p><strong>Dolvic-K</strong><strong><sup>&reg;</sup></strong> tablets relieve pain, reduce swelling and ease inflammation in:</p><p>Rheumatoid arthritis, osteoarthrosis, acute gout, low back pain, ankylosing spondolytis.</p><p>Migraine.</p><p>Conditions affecting the joints and muscles such as sprains and strains, soft tissue sports injuries, frozen shoulder, dislocations, and fractures.</p><p>Conditions affecting the tendons for example, tendonitis, tenosynovitis, bursitis.</p><p>They are also used to treat pain and inflammation associated with orthopaedic, dental and other minor surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Dolvic-K</strong><strong><sup>&reg;</sup></strong><strong>, and talk to your doctor:</strong></p><p>If you think you may be allergic to diclofenac potassium, aspirin, ibuprofen or any other NSAID, or to any of the other ingredients of <strong>Dolvic-K</strong><strong><sup>&reg; </sup></strong>tablets. Signs of a hypersensitivity reaction include swelling of the face and mouth (angioedema), breathing problems, runny nose, skin rash or any other allergic type reaction.</p><p>If you have now, or have ever had, a stomach (gastric) or duodenal (peptic) ulcer, or bleeding in the digestive tract (this can include blood in vomit, bleeding when emptying bowels, fresh blood in faeces or black, tarry faeces).</p><p>If you have had stomach or bowel problems after you have taken other NSAIDs.</p><p>If you have severe heart, kidney or liver failure.</p><p>If you have established heart disease and/or cerebrovascular disease e.g. if you have had a heart attack, stroke, mini-stroke (TIA) or blockages to blood vessels to the heart or brain or an operation to clear or bypass blockages.</p><p>If you have or have had problems with your blood circulation (peripheral arterial disease).</p><p>If you are more than six months pregnant.</p><p><strong>Take special care with Dolvic-K</strong><strong><sup>&reg;</sup></strong></p><p><strong>You should also ask yourself these questions before taking Dolvic-K</strong><strong><sup>&reg;</sup></strong><strong>:</strong></p><p>If you suffer from any stomach or bowel disorders including ulcerative colitis or Crohn&rsquo;s disease.</p><p>If you have kidney or liver problems, or you are elderly.</p><p>If you have a condition called porphyria.</p><p>If you suffer from any blood or bleeding disorder, your doctor may ask you to go for regular check-ups while you are taking these tablets.</p><p>If you have ever had asthma.</p><p>If you are breast-feeding.</p><p>If you have angina, blood clots, high blood pressure, raised cholesterol or raised triglycerides.</p><p>If you have heart problems, or have you had a stroke, or you think you might be at risk of these conditions (for example, if you have high blood pressure, diabetes, or high cholesterol or are a smoker).</p><p>If you have diabetes.</p><p>If you smoke.</p><p>If you have Lupus (SLE) or any similar condition.</p><p>If you have an intolerance to some sugars such as lactose (<strong>Dolvic-K</strong><strong><sup>&reg; </sup></strong>Tablets contain Lactose).</p><p><strong>Other medicines and Dolvic-K</strong><strong><sup>&reg;</sup></strong></p><p>Some medicines can interfere with your treatment. Tell your doctor or pharmacist if you are taking any of the following:</p><p>Medicines to treat diabetes.</p><p>Anticoagulants (blood thinning tablets like warfarin).</p><p>Diuretics (water tablets).</p><p>Lithium (used to treat some mental problems).</p><p>Methotrexate (for some inflammatory diseases and some cancers).</p><p>Ciclosporin and tacrolimus (used to treat some inflammatory diseases and after transplants).</p><p>Trimethoprim (a medicine used to prevent or treat urinary tract infections).</p><p>Quinolone antibiotics (for infections).</p><p>Any other NSAID or COX-2 (cyclo-oxgenase-2) inhibitor, for example aspirin or ibuprofen.</p><p>Mifepristone (a medicine used to terminate pregnancy).</p><p>Cardiac glycosides (for example digoxin), used to treat heart problems.</p><p>Medicines known as SSRIs used to treat depression.</p><p>Oral steroids (an anti-inflammatory drug).</p><p>Medicines used to treat heart conditions or high blood pressure, for example beta-blockers or ACE inhibitors.</p><p>Voriconazole (a medicine used to treat fungal infections).</p><p>Phenytoin (a medicine used to treat seizures).</p><p>Colestipol/cholestyramine (used to lower cholesterol).</p><p>Always tell your doctor or pharmacist about all the medicines you are taking. This means medicines you have bought yourself as well as medicines on prescription from your doctor.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>Do not take diclofenac potassium tablets if you are in the last 3 months of pregnancy as it could harm your unborn child or cause problems at delivery. It can cause kidney and heart problems in your unborn baby. It may affect your and your baby&rsquo;s tendency to bleed and cause labour to be later or longer than expected. You should not take diclofenac potassium tablets during the first 6 months of pregnancy unless absolutely necessary and advised by your doctor. If you need treatment during this period or while you are trying to get pregnant, the lowest dose for the shortest time possible should be used. If taken for more than a few days from 20 weeks of pregnancy onward, diclofenac potassium tablets can cause kidney problems in your unborn baby that may lead to low levels of amniotic fluid that surrounds the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the heart of the baby. If you need treatment for longer than a few days, your doctor may recommend additional monitoring.</p><p>If you are trying for a baby, taking diclofenac potassium tablets may make it more difficult to conceive. You should talk to your doctor if you are planning to become pregnant, or if you have problems getting pregnant.</p><p><strong>Driving or using machines</strong></p><p>Very occasionally people have reported that diclofenac potassium tablets have made them feel dizzy, tired or sleepy. Problems with eyesight have also been reported. If you are affected in this way, you should not drive or operate machinery.</p><p><strong>Other special warnings</strong></p><p>You should take the lowest dose of <strong>Dolvic-K</strong><strong><sup>&reg;</sup></strong> for the shortest possible time, particularly if you are underweight or elderly.</p><p>There is a small increased risk of heart attack or stroke when you are taking any medicine like <strong>Dolvic-K</strong><strong><sup>&reg;</sup></strong>. The risk is higher if you are taking high doses for a long time. Always follow the doctor&rsquo;s instructions on how much to take and how long to take it for.</p><p>If at any time while taking <strong>Dolvic-K</strong><strong><sup>&reg;</sup></strong> you experience any signs or symptoms of problems with your heart or blood vessels such as chest pain, shortness of breath, weakness, or slurring of speech, contact your doctor immediately.</p><p>Whilst you are taking these medicines your doctor may want to give you a check-up from time to time.</p><p>If you have a history of stomach problems when you are taking NSAIDs, particularly if you are elderly, you must tell your doctor straight away if you notice any unusual symptoms.</p><p>Because it is an anti-inflammatory medicine, <strong>Dolvic-K</strong><strong><sup>&reg;</sup></strong> may reduce the symptoms of infection, for example, headache and high temperature. If you feel unwell and need to see a doctor, remember to tell him or her that you are taking <strong>Dolvic-K</strong><strong><sup>&reg;</sup></strong>.</p><p><strong>Dolvic-K</strong><strong><sup>&reg;</sup></strong> <strong>tablets contain lactose </strong></p><p>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>The doctor will tell you how many <strong>Dolvic-K</strong><strong><sup>&reg; </sup></strong>tablets to take and when to take them.</p><p>Always follow his/her instructions carefully. The dose will be on the pharmacist&rsquo;s label. Check the label carefully. If you are not sure, ask your doctor or pharmacist. Keep taking your tablets for as long as you have been told, unless you have any problems. In that case, check with your doctor.</p><p>Take the tablets with or after food. Swallow the tablets whole with a drink of water. Do not crush or chew them.</p><p><strong>The usual doses are:</strong></p><p><strong>Adults</strong></p><p>75 mg to 150 mg daily divided into two or three doses. The number of tablets you take will depend on the strength the doctor has given you.</p><p><strong>For the relief of migraine in adults:</strong></p><p>Take 50 mg at the first signs of an attack. If the migraine has not gone after 2 hours, take another 50 mg. You can take further doses at intervals of 4 to 6 hours if necessary, but you must not take more than 200 mg in a day.</p><p><strong>Elderly</strong></p><p>Your doctor may advise you to take a dose that is lower than the usual adult dose if you are elderly. Your doctor may also want to check closely that the <strong>Dolvic-K</strong><strong><sup>&reg; </sup></strong>tablets are not affecting your stomach.</p><p><strong>Children over 14</strong></p><p>75 mg to 100 mg daily divided into two or three doses.</p><p><strong>Dolvic-K</strong><strong><sup>&reg; </sup></strong>is not recommended for children under 14. They are not recommended for the treatment of migraine in children of any age.</p><p>The doctor may also prescribe another drug to protect the stomach to be taken at the same time, particularly if you have had stomach problems before, or if you are elderly, or taking certain other drugs as well.</p><p><strong>If you forget to take a dose</strong></p><p>If you forget to take a dose, take one as soon as you remember. If it is nearly time for your next dose, though, just take the next dose and forget about the one you missed. Do not double up on the next dose to make up for the one missed. Do not take more than 150 mg (three 50 mg tablets) in 24 hours.</p><p><strong>If you take Dolvic-K</strong><strong><sup>&reg; </sup></strong><strong>tablets more than you should</strong></p><p>If you, or anyone else, accidentally takes too much, tell your doctor or your nearest hospital casualty department. Take your medicine pack with you so that people can see what you have taken.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Dolvic-K</strong><strong><sup>&reg; </sup></strong>tablets are suitable for most people, but, like all medicines, they can sometimes cause side effects. Side effects may be minimised by using the lowest effective dose for the shortest duration necessary.</p><p><strong>Some side effects can be serious</strong></p><p><strong>Stop taking Diclofenac Potassium and tell your doctor straight away if you notice:</strong></p><p>Sudden and crushing chest pain (signs of myocardial infarction or heart attack).</p><p>Breathlessness, difficulty breathing when lying down, swelling of the feet or legs (signs of heart failure).</p><p>Sudden weakness or numbness in the face, arm or leg especially on one side of the body; sudden loss or disturbance of vision; sudden difficulty in speaking or ability to understand speech; sudden migraine-like headaches which happen for the first time, with or without disturbed vision. These symptoms can be an early sign of a stroke.</p><p>Stomach pain, indigestion, heartburn, wind, nausea (feeling sick) or vomiting (being sick).</p><p>Any sign of bleeding in the stomach or intestine, for example, when emptying your bowels, blood in vomit or black, tarry faeces.</p><p>Allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling or blistering.</p><p>Wheezing or shortness of breath (bronchospasm).</p><p>Swollen face, lips, hands or fingers.</p><p>Yellowing of your skin or the whites of your eyes.</p><p>Persistent sore throat or high temperature.</p><p>An unexpected change in the amount of urine produced and/or its appearance.</p><p>Mild cramping and tenderness of the abdomen, starting shortly after the start of the treatment with diclofenac potassium<strong> </strong>and followed by rectal bleeding or bloody diarrhea usually within 24 hours of the onset of abdominal pain.</p><p>Chest pain, which can be a sign of a potentially serious allergic reaction called Kounis syndrome.</p><p>If you notice that you are bruising more easily than usual or have frequent sore throats or infections, tell your doctor.</p><p><strong>The side effects listed below have also been reported:</strong></p><p><strong>Common side effects (These may affect between 1 and 1 in 10 in every 100 patients):</strong></p><p>Stomach pain, heartburn, nausea, vomiting, diarrhea, indigestion, wind, loss of appetite.</p><p>Headache, dizziness, vertigo.</p><p>Skin rash or spots.</p><p>Raised levels of liver enzymes in the blood.</p><p><strong>Uncommon side effects (These may affect between 1 and 10 in every 1000 patients):</strong></p><p>Fast or irregular heart beat (palpitations), chest pain, heart disorders, including heart attack or breathlessness, difficulty breathing when lying down, or swelling of the feet or legs (signs of heart failure), especially if you have been taking a higher dose (150 mg per day) for a long period of time.</p><p><strong>Rare side effects (These may affect between 1 in every 1000 to 1 in every 10,000 patients):</strong></p><p>Stomach ulcers or bleeding (there have been very rare reported cases resulting in death, particularly in the elderly).</p><p>Gastritis (inflammation, irritation or swelling of the stomach lining).</p><p>Vomiting blood.</p><p>Diarrhea with blood in it or bleeding from the back passage.</p><p>Black, tarry faeces or stools.</p><p>Drowsiness, tiredness.</p><p>Skin rash and itching.</p><p>Fluid retention, symptoms of which include swollen ankles.</p><p>Liver function disorders, including hepatitis and jaundice.</p><p>Asthma (symptoms may include wheezing, breathlessness, coughing and a tightness across the chest).</p><p><strong>Very rare side effects (These may affect less than 1 in every 10,000 patients):</strong></p><p><u>Effects on the nervous system:</u></p><p>Inflammation of the lining of the brain (meningitis), tingling or numbness in the fingers, tremor, visual disturbances such as blurred or double vision, hearing loss or impairment, tinnitus (ringing in the ears), sleeplessness, nightmares, mood changes, depression, anxiety, irritability, mental disorders, disorientation and loss of memory, fits, headaches together with a dislike of bright lights, fever and a stiff neck.</p><p><u>Effects on the stomach and digestive system:</u></p><p>Constipation, inflammation of the tongue, mouth ulcers, inflammation of the inside of the mouth or lips, taste changes, lower gut disorders (including inflammation of the colon or worsening of ulcerative colitis or Crohn&rsquo;s disease), inflammation of the pancreas.</p><p><u>Effects on the chest or blood:</u></p><p>Hypertension (high blood pressure), hypotension (low blood pressure, symptoms of which may include faintness, giddiness or light headedness), inflammation of blood vessels (vasculitis), inflammation of the lung (pneumonitis), blood disorders (including anaemia).</p><p><u>Effects on the liver or kidneys:</u></p><p>Kidney or severe liver disorders including liver failure, presence of blood or protein in the urine.</p><p><u>Effects on skin or hair:</u></p><p>Facial swelling, serious skin rashes including Stevens-Johnson syndrome and Lyell&rsquo;s syndrome and other skin rashes which may be made worse by exposure to sunlight.</p><p>Hair loss.</p><p><u>Effects on the reproductive system:</u></p><p>Impotence.</p><p><strong>Other side effects that have also been reported with unknown frequency include</strong>:</p><p>Throat disorders, confusion, hallucinations, malaise (general feeling of discomfort), inflammation of the nerves in the eye, disturbances of sensation.</p><p>Medicines such as diclofenac may be associated with a small increased risk of heart attack or stroke.</p><p>Do not be alarmed by this list - most people take<strong> Dolvic-K</strong><strong><sup>&reg;</sup></strong> tablets without any problems.</p><p><strong>If you get any side effects, talk your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Do not use <strong>Dolvic-K</strong><strong><sup>&reg; </sup></strong>after the expiry date (EXP) which is stated on the blister and the carton.</p><p>The expiry date refers to the last day of that month.</p><p><strong>Dolvic-K</strong><strong><sup>&reg; </sup></strong>tablets: Store below 30&deg;C.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Diclofenac Potassium.</p><p>The other ingredients are Lactose monohydrate, sodium starch glycolate, maize starch, magnesium stearate, talc, red iron oxide, Opadry OY-L white (lactose monohydrate, HPMC/hypromellose, titanium dioxide, macrogol/PEC), polyethylene glycol, copovidone, microcrystalline cellulose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Dolvic-K® 50 mg: round, deep convex, reddish brown, non-scored film coated tablets engraved with L12 and plain on the other side, presented in PVC/TE/PVDC/Alu blisters, intended for oral use. 
Pack sizes: 20 Film Coated Tablets (10 tablets/blister, 2 blisters/pack).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Med City Pharma-KSA.</p><p>1st Industrial city, Phase 5, Jeddah &ndash;KSA.</p><p>Tel: 00966920003288</p><p>Mobile: 00966555786968</p><p>P.O .Box: 4072 - Jeddah 22429</p><p>E-mail: info@medcitypharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                07/2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ديكلوفيناك بوتاسيوم، هي المادة الفعالة في أقراص <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong>، و التي تنتمي إلى مجموعة من الأدوية تعرف بالأدوية غير الستيرويدية المضادة للالتهاب، والتي تعمل على تخفيف الألم والالتهاب.</p><p dir="RTL">تخفف أقراص <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg; </sup></strong>الألم، و تقلل التورم و الالتهاب في الحالات التالية:</p><p dir="RTL">التهاب المفاصل الروماتزمي، التهاب عظمي مفصلي، النقرس الحاد، ألم أسفل الظهر، التهاب الفقار القسطي.</p><p dir="RTL">&nbsp;الصداع النصفي.</p><p dir="RTL">الحالات التي تؤثر على المفاصل والعضلات مثل التواء المفصل بدون خلعه (فكش) والإجهاد، إصابات الأنسجة الرخوة الناتجة عن ممارسة الرياضة، تصلب عضلات الكتف، الخلع، و الكسور.</p><p dir="RTL">الحالات التي تؤثر على الأوتار مثل التهاب الأوتار، التهاب غمد الوتر (معص)، التهاب الجراب.</p><p dir="RTL">قد تستعمل أيضاً لعلاج الألم و الالتهاب المصاحب لعمليات جراحة العظام، و الأسنان والعمليات الصغرى الأخرى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب</strong><strong> </strong><strong>عدم</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong><strong>،</strong><strong><sup> </sup></strong><strong>وتحدث</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>في</strong><strong> </strong><strong>الحالات</strong><strong> </strong><strong>التالية</strong><strong>:</strong></p><p dir="RTL">إذا كنت تعتقد بأنك قد تعاني من التحسس لديكلوفيناك البوتاسيوم، الأسبرين، الأيبوبروفين أو أي أدوية أخرى من الأدوية غير الستيرويدية المضادة للالتهاب، أو لأي مكونات أخرى في أقراص <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong>. تتضمن علامات تفاعل فرط التحسس: تورم الوجه والفم (وذمة وعائية)، مشاكل في التنفس، سيلان الأنف، طفح جلدي أو أي نوع آخر من تفاعلات التحسس.</p><p dir="RTL">إذا كنت تعاني حالياً، أو عانيت في السابق من قرحة في المعدة أو الإثني عشر (هضمية)، أو نزيف في القناة الهضمية (قد تتضمن الأعراض ظهور الدم في القيء، نزيف عند الإخراج، ظهور الدم في البراز أو براز أسود، قطراني).</p><p dir="RTL">إذا كنت تعاني أو عانيت في السابق من مشاكل في المعدة أو الأمعاء بعد تناولك أي من الأدوية غير الستيرويدية المضادة للالتهاب الأخرى.</p><p dir="RTL">إذا كنت تعاني من قصور حاد في وظيفة عضلة القلب، الكلى أو الكبد.</p><p dir="RTL">إذا عانيت من مرض في القلب و/أو مرض وعائي دماغي، على سبيل المثال إذا عانيت في السابق من نوبة قلبية، سكتة دماغية، السكتة الدماغية التي تستمر لفترة قصيرة (النوبة المؤقتة الناتجة عن توقف تدفق الدم إلى الدماغ لفترة قصيرة) أو انسداد في الأوعية الدموية المتجهة إلى القلب أو الدماغ أو الخضوع لعملية لإزالة الانسداد أو عملية الترقيع التحويلية للشرايين التاجية.</p><p dir="RTL">إذا كنت تعاني أو عانيت&nbsp; في السابق من مشاكل في الدورة الدموية (مرض شرياني طرفي).</p><p dir="RTL">إذا كنت حاملاً لمدة تزيد عن ستة شهور.</p><p dir="RTL"><strong>الإحتياطات</strong><strong> </strong><strong>الخاصة</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL"><strong>يجب</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تسأل</strong><strong> </strong><strong>نفسك</strong><strong> </strong><strong>أيضا</strong><strong> </strong><strong>الأسئلة</strong><strong> </strong><strong>التالية</strong><strong> </strong><strong>قبل</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong><strong> </strong></p><p dir="RTL">&nbsp;إذا كنت تعاني من أي اضطرابات في المعدة أو الأمعاء تتضمن التهاب القولون التقرحي أو مرض كرون.</p><p dir="RTL">إذا كنت تعاني من مشاكل في الكلى أو الكبد، أو كنت من كبار السن.</p><p dir="RTL">إذا كنت تعاني من حالة تسمى برفرية.</p><p dir="RTL">إذا كنت تعاني من أي اضطراب في الدم أو النزيف، قد يطلب طبيبك القيام بفحوصات دورية خلال فترة تناولك هذه الأقراص.</p><p dir="RTL">إذا عانيت في السابق من الربو.</p><p dir="RTL">إذا كنت مرضعة.</p><p dir="RTL">إذا كنت تعاني من الذبحة الصدرية، الجلطات الدموية، ارتفاع ضغط الدم، ارتفاع مستوى الكوليستيرول أو ارتفاع مستوى الدهون الثلاثية.</p><p dir="RTL">إذا كنت تعاني من مشاكل في القلب، أو عانيت في السابق من سكتة دماغية، أو كنت تعتقد بأنك قد تكون معرض لخطر الإصابة بهذه الحالات (على سبيل المثال، إذا كنت تعاني من ارتفاع ضغط الدم، داء السكري، أو ارتفاع مستوى الكوليستيرول أو مدخن).</p><p dir="RTL">إذا كنت تعاني من داء السكري.</p><p dir="RTL">إذا كنت مدخن.</p><p dir="RTL">إذا كنت تعاني من الذأب (الذأب الحمامى الجهازي) أو أي حالة مشابهة.</p><p dir="RTL">إذا كنت تعاني من عدم القدرة على تحمل بعض أنواع السكريات مثل اللاكتوز (تحتوي أقراص <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg; </sup></strong>على اللاكتوز).</p><p dir="RTL"><strong>الأدوية</strong><strong> </strong><strong>الأخرى</strong><strong> </strong><strong>و</strong><strong> </strong><strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong></p><p dir="RTL">قد تؤثر بعض الأدوية على علاجك. أخبر طبيبك أو الصيدلي إذا كنت تتناول أي من الأدوية التالية:</p><p dir="RTL">أدوية لعلاج داء السكري.</p><p dir="RTL">مضادات التجلط (أدوية للوقاية من تجلط الدم مثل الوارفارين).</p><p dir="RTL">مدرات البول (أقراص الماء).</p><p dir="RTL">الليثيوم (يستعمل لعلاج بعض المشاكل العقلية).</p><p dir="RTL">ميثوتريكسيت (لعلاج بعض الأمراض الالتهابية و بعض السرطانات).</p><p dir="RTL">سايكلوسبورين و تاكروليمس (يستعمل لعلاج بعض الأمراض الالتهابية و بعد زراعة الأعضاء).</p><p dir="RTL">ترايميثوبريم (دواء يستعمل لعلاج أو للوقاية من التهابات الجهاز البولي).</p><p dir="RTL">المضادات الحيوية من مجموعة كوينولون (لعلاج الالتهابات).</p><p dir="RTL">أي دواء آخر من الأدوية غير الستيرويدية المضادة للالتهاب أو إحدى مثبطات سايكلوأوكسيجينيز-2، مثل الأسبرين أو الأيبوبروفين.</p><p dir="RTL">ميفيبريستون (دواء يستعمل لإجهاض الحمل).</p><p dir="RTL">الجلايكوسيدات القلبية (مثل ديجوكسين)، يستعمل لعلاج مشاكل القلب.</p><p dir="RTL">أدوية تعرف بمثبطات إعادة امتصاص السيروتونين الانتقائية تستعمل لعلاج الاكتئاب.</p><p dir="RTL">الستيرويدات التي يتم تناولها عن طريق الفم (دواء مضاد للالتهاب).</p><p dir="RTL">أدوية تستعمل لعلاج حالات قلبية أو ارتفاع ضغط الدم، مثل حاصرات بيتا أو مثبطات الإنزيم المحوّل للأنجيوتنسين.</p><p dir="RTL">ڤوريكونازول (دواء يستعمل لعلاج الالتهابات الفطرية).</p><p dir="RTL">فينيتوين (دواء يستعمل لعلاج نوبات الصرع).</p><p dir="RTL">كوليستيبول/كوليستيرامين (أدوية تستعمل لتخفيض مستوى الكوليستيرول).</p><p dir="RTL">دائماً أخبر طبيبك أو الصيدلي عن جميع الأدوية التي تتناولها. وهذا يعني الأدوية التي حصلت عليها بنفسك بدون وصفة طبية و الأدوية التي وصفها لك الطبيب.&nbsp;</p><p dir="RTL"><strong>الحمل</strong><strong> </strong><strong>و</strong><strong> </strong><strong>الرضاعة</strong><strong> </strong><strong>الطبيعية</strong></p><p dir="RTL">تجنبي تناول ديكلوفيناك البوتاسيوم إذا كنت في الأشهر الثلاثة الأخيرة من الحمل، لأن ذلك قد يؤذي الجنين أو يسبب مشاكل عند الولادة. قد يسبب مشاكل في الكلى و القلب عند الجنين. قد يؤثر على قابلية النزيف لديك أو لطفلك و قد يسبب تأخر المخاض أو أطول من المتوقع.</p><p dir="RTL">يجب تجنب تناول ديكلوفيناك البوتاسيوم في الأشهر الستة الأولى من الحمل إلا إذا كان في غاية الضرورة و نصحك به طبيبك. إذا كنت بحاجة للعلاج خلال هذه الفترة أو خلال محاولة الحمل، يجب تناول أقل جرعة لأقل فترة ممكنة. إذا تم تناوله لأكثر من بضعة أيام من الأسبوع رقم 20 من الحمل، قد يسبب ديكلوفيناك البوتاسيوم مشاكل في الكلى عند الجنين و هذا قد يسبب انخفاض مستويات السائل الأمنيوتي الذي يحيط بالطفل (قلة السائل السلوي) أو تضيق في الوعاء الدموي (القناة الشريانية) في قلب الطفل، إذا كنت بحاجة للعلاج لمدة أكثر من بضعة أيام، قد يوصي طبيبك بمراقبة إضافية.</p><p dir="RTL">إذا كنت تخططين للحمل، إن تناول أقراص ديكلوفيناك البوتاسيوم قد يجعل حدوثه صعب، لذلك يجب عليك التحدث مع طبيبك إذا كنت تخططين للحمل، أو إذا عانيت من مشاكل في حدوثه.</p><p dir="RTL"><strong>قيادة</strong><strong> </strong><strong>المركبات</strong><strong> </strong><strong>و</strong><strong> </strong><strong>استخدام</strong><strong> </strong><strong>الآلات</strong></p><p dir="RTL">في كثير من الأحيان تم تسجيل أن أقراص ديكلوفيناك بوتاسيوم سببت الشعور بالدوار، التعب أو النعاس. تم تسجيل أيضاً حدوث مشاكل في الرؤية. يجب عليك تجنب القيادة أو تشغيل الآلات إذا&nbsp; تأثرت بهذه الطريقة.</p><p dir="RTL"><strong>تحذيرات</strong><strong> </strong><strong>خاصة</strong><strong> </strong><strong>أخرى</strong><strong> </strong></p><p dir="RTL">يجب عليك تناول أقل جرعة من <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong><strong> </strong>لأقصر فترة ممكنة، خصوصاً إذا كنت تعاني من انخفاض الوزن عن المعدل الطبيعي أو كنت من كبار السن.</p><p dir="RTL">يزداد خطر التعرض بشكل بسيط للنوبة القلبية أو السكتة الدماغية خلال فترة تناولك أي دواء مثل <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong>. ويكون الخطر أكبر عند تناول جرعات عالية لمدة أطول. دائماً اتبع تعليمات الطبيب المتعلقة بالجرعة ومدة الاستعمال.</p><p dir="RTL">في أي وقت خلال فترة تناول <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg; </sup></strong>إذا عانيت من أي علامات أو أعراض لمشاكل في القلب أو الأوعية الدموية مثل ألم في الصدر، قصر النفس، الشعور بالضعف، أو تلعثم الكلام، اتصل مع طبيبك فورا.</p><p dir="RTL">خلال فترة تناولك هذه الأدوية قد يطلب منك الطبيب القيام بفحوصات من وقت لآخر.</p><p dir="RTL">إذا عانيت في السابق من مشاكل في المعدة عند تناولك إحدى الأدوية غير الستيرويدية المضادة للالتهاب، خصوصاً إذا كنت من كبار السن، يجب عليك إخبار طبيبك على الفور إذا لاحظت ظهور أي أعراض غير معتادة.</p><p dir="RTL">لأن هذا الدواء من الأدوية المضاد للالتهاب، قد يقلل <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong> أعراض الالتهاب مثل الصداع، وارتفاع درجة حرارة الجسم. إذا لم تشعر بتحسن وشعرت بأنك تحتاج لزيارة الطبيب، تذكر إخباره بأنك تتناول <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong>.&nbsp;</p><p dir="RTL"><strong>تحتوي</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong><strong> </strong><strong>على</strong><strong> </strong><strong>اللاكتوز</strong><strong> </strong></p><p dir="RTL">إذا أخبرت من قبل الطبيب بأنك تعاني من عدم القدرة على تحمل بعض أنواع السكريات، اتصل مع طبيبك قبل تناول هذا المستحضر الدوائي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائما تناول هذا الدواء تماما كما أخبرك طبيبك. تأكد من طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p dir="RTL">سيخبرك الطبيب عن الجرعة التي يجب تناولها من أقراص <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg; </sup></strong>و وقت تناولها.</p><p dir="RTL">دائما اتبع تعليمات الطبيب بحذر. الجرعة موجودة على الملصق الذي يضعه الصيدلي. تأكد من الملصق بحذر. إذا لم تكن متأكداً اسأل طبيبك أو الصيدلي. استمر في تناول الأقراص كما أخبرك الطبيب، ما لم تعاني من أي مشاكل. في هذه الحالة تأكد من طبيبك.</p><p dir="RTL">تناول الأقراص مع أو بعد تناول الطعام. تناول القرص كاملاً مع شرب الماء. تجنب طحن الأقراص أو مضغها.</p><p dir="RTL"><strong>الجرعات</strong><strong> </strong><strong>المعتادة</strong><strong> </strong><strong>هي</strong><strong>:</strong></p><p dir="RTL"><strong>البالغون</strong></p><p dir="RTL">75 ملغم إلى 150 ملغم يومياً مقسمة على جرعتين أو ثلاث جرعات. سيعتمد عدد الأقراص التي تتناولها على الجرعة التي وصفها لك الطبيب.</p><p dir="RTL"><strong>لتخفيف</strong><strong> </strong><strong>الصداع</strong><strong> </strong><strong>النصفي</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>البالغين</strong><strong>:</strong></p><p dir="RTL">تناول 50 ملغم عند ظهور أول علامات للنوبة. إذا لم يختفي الصداع النصفي بعد ساعتين، تناول قرص آخر 50 ملغم، من الممكن تناول جرعات إضافية خلال فترة 4 إلى 6 ساعات عند الحاجة، لكن يجب عدم تناول أكثر من 200 ملغم في اليوم.</p><p dir="RTL"><strong>كبار</strong><strong> </strong><strong>السن</strong></p><p dir="RTL">قد ينصحك الطبيب بتناول جرعة أقل من الجرعة المعتادة للبالغين إذا كنت من كبار السن. قد يحتاج طبيبك أيضاً التأكد جيداً من أن أقراص <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong> لا تؤثر على معدتك.</p><p dir="RTL"><strong>الأطفال</strong><strong> </strong><strong>الأكبر</strong><strong> </strong><strong>من</strong><strong> 14 </strong><strong>عاماً</strong></p><p dir="RTL">75 ملغم إلى 100 ملغم يومياً مقسمة على جرعتين أو ثلاث جرعات.</p><p dir="RTL">لا يوصى باستعمال أقراص<strong> </strong><strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong><strong> </strong>للأطفال الذين تقل أعمارهم عن 14 عاماً. و غير موصى به لعلاج الصداع النصفي عند الأطفال في أي عمر.</p><p dir="RTL">قد يصف الطبيب أيضاً دواء آخر لحماية المعدة ويتم تناوله في نفس الوقت، خصوصاً إذا عانيت من مشاكل في المعدة سابقاً، أو إذا كنت من كبار السن، أو كنت تتناول أدوية معينة أخرى.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>نسيت</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>جرعة</strong></p><p dir="RTL">إذا نسيت تناول جرعة، تناولها حال تذكرك. إذا اقترب موعد الجرعة التالية، تناولها واترك الجرعة التي نسيتها. لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها. لا تتناول أكثر من 150 ملغم (3 أقراص 50 ملغم) خلال 24 ساعة.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>تناولت</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg; </sup></strong><strong>&nbsp;</strong><strong>أكثر</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يجب</strong></p><p dir="RTL">&nbsp;إذا تناولت أنت، أو أي شخص آخر، الكثير من الأقراص عن طريق الخطأ، أخبر طبيبك أو قسم الطوارىء في أقرب مستشفى. اصطحب معك عبوة الدواء ليرى الطبيب ماذا تناولت.</p><p dir="RTL">إذا كان لديك أي أسئلة إضافية عن استعمال هذا الدواء، إسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثار جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">تعد أقراص <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg; </sup></strong>مناسبة لمعظم الأشخاص، لكن، مثل جميع الأدوية، قد تسبب أحياناً آثاراً جانبية. من الممكن تقليل خطر التعرض للآثار الجانبية عن طريق استعمال أقل جرعة فعالة لأقصر مدة مطلوبة.</p><p dir="RTL"><strong>قد</strong><strong> </strong><strong>تكون</strong><strong> </strong><strong>بعض</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>خطيرة</strong></p><p dir="RTL"><strong>توقف</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>ديكلوفيناك</strong><strong> </strong><strong>بوتاسيوم</strong><strong> </strong><strong>و</strong><strong> </strong><strong>أخبر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>على</strong><strong> </strong><strong>الفور</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لاحظت</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يلي</strong><strong>:</strong></p><p dir="RTL">ألم شديد ومفاجئ في الصدر (علامات احتشاء عضلة القلب أو نوبة قلبية).</p><p dir="RTL">ضيق النفس، صعوبة التنفس عند الاستلقاء، تورم القدمين أو الساقين (علامات قصور وظيفة عضلة القلب).</p><p dir="RTL">الشعور المفاجئ بالضعف أو تنميل في الوجه، الذراع أو الساق خاصة في جانب واحد من الجسم. فقدان مفاجئ أو اضطراب في الرؤية، صعوبة مفاجئة في الكلام أو القدرة على فهم الكلام؛ صداع مفاجئ شبيه بالصداع النصفي يحدث لأول مرة مع أو بدون حدوث اضطراب في الرؤية. يمكن أن تكون هذه الأعراض علامة مبكرة على الإصابة بسكتة دماغية.</p><p dir="RTL">ألم في المعدة، عسر الهضم، حرقة، غازات، الشعور بالغثيان أو قيء.</p><p dir="RTL">أي علامة للنزيف في المعدة أو الأمعاء، على سبيل المثال عند الإخراج، ظهور دم في القيء، أو براز أسود قطراني.</p><p dir="RTL">تفاعلات تحسسية التي قد تتضمن طفح، حكة، ظهور الكدمات، ظهور مناطق حمراء مؤلمة على الجلد، تقشر أو تنفط (بثور).</p><p dir="RTL">أزيز تنفسي أو قصر النفس (تشنج قصبي).</p><p dir="RTL">تورم الوجه، الشفاه، الأيدي أو الأصابع.</p><p dir="RTL">اصفرار الجلد أو المنطقة البيضاء في العيون.</p><p dir="RTL">التهاب الحلق المستمر أو ارتفاع درجة حرارة الجسم.</p><p dir="RTL">تغير غير متوقع في كمية البول المنتج و/أو مظهره.</p><p dir="RTL">تشنجات معتدلة في البطن والتألم باللمس في منطقة البطن، تبدأ بعد فترة قصيرة من بدء العلاج باستعمال أقراص ديكلوفيناك بوتاسيوم ويتبعها نزيف في المستقيم أو إسهال مصحوب بظهور الدم عادة خلال 24 ساعة من بدء الشعور بآلام البطن.</p><p dir="RTL">ألم في الصدر، والذي قد يكون علامة على حدوث تفاعل تحسسي خطير محتمل يسمى متلازمة كونس.</p><p dir="RTL">أخبر طبيبك إذا لاحظت بأنك تتعرض للكدمات بسهولة أكثر من المعتاد أو عانيت من تقرح أو التهاب متكرر في الحلق.</p><p dir="RTL"><strong>سجلت</strong><strong> </strong><strong>أيضاً</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>التالية</strong><strong>:</strong></p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>شائعة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>بين</strong><strong> 1 </strong><strong>و</strong><strong> 1 </strong><strong>من</strong><strong> 10 </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 100 </strong><strong>مريض</strong><strong>):</strong></p><p dir="RTL">ألم في المعدة، حرقة، الشعور بالغثيان، قيء، إسهال، عسر هضم، غازات، فقدان الشهية.</p><p dir="RTL">صداع، الشعور بالدوار، رنح.</p><p dir="RTL">طفح جلدي أو بقع.</p><p dir="RTL">ارتفاع مستويات إنزيمات الكبد في الدم.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>شائعة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>بين</strong><strong> 1 </strong><strong>و</strong><strong> 10 </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 1000 </strong><strong>مريض</strong><strong>):</strong></p><p dir="RTL">تسارع أو عدم انتظام نبضات القلب (خفقان)، ألم في الصدر، اضطرابات في القلب، تتضمن النوبة القلبية أو ضيق النفس، صعوبة التنفس عند الاستلقاء، أو تورم القدمين أو الساقين (علامات لقصور وظيفة عضلة القلب)، خصوصا إذا كنت تتناول أعلى جرعة (150 ملغم يوميا) لفترة طويلة من الوقت.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>نادرة</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>بين</strong><strong> 1 </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 1000 </strong><strong>إلى</strong><strong> 1 </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10000 </strong><strong>مريض</strong><strong>):</strong></p><p dir="RTL">تقرحات أو نزيف في المعدة (تم تسجيل حالات نادرة جداً نتج عنها الوفاة، خصوصاً عند كبار السن).</p><p dir="RTL">التهاب المعدة (التهاب، تهيج أو تورم بطانة المعدة).</p><p dir="RTL">تقيؤ الدم.</p><p dir="RTL">إسهال يرافقة ظهور الدم أو نزيف من فتحة الشرج.</p><p dir="RTL">براز أسود قطراني.</p><p dir="RTL">الشعور بالنعاس أو التعب.</p><p dir="RTL">طفح جلدي و حكة.</p><p dir="RTL">احتباس السوائل، قد تتضمن الأعراض تورم الكاحلين.</p><p dir="RTL">اضطرابات في وظيفة الكبد، تتضمن التهاب الكبد و اليرقان.</p><p dir="RTL">ربو (قد تتضمن الأعراض أزيز تنفسي، ضيق النفس، سعال و ضيق في الصدر).</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>نادرة</strong><strong> </strong><strong>جداً</strong><strong> (</strong><strong>قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>على</strong><strong> </strong><strong>أقل</strong><strong> </strong><strong>من</strong><strong> 1 </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 10000 </strong><strong>مريض</strong><strong>):</strong></p><p dir="RTL"><u>التأثيرات</u><u> </u><u>على</u><u> </u><u>الجهاز</u><u> </u><u>العصبي</u><u>:</u></p><p dir="RTL">التهاب بطانة الدماغ (التهاب السحايا)، إحساس بوخز خفيف أو تنميل في الأصابع، رعاش، اضطرابات بصرية مثل ضبابية أو ازدواجية الرؤية، فقدان السمع أو ضعفه، طنين (رنين في الأذنين)، الأرق، كوابيس، تغيرات في المزاج، اكتئاب، قلق، تهيج، اضطرابات عقلية، الشعور بالتوهان وفقدان الذاكرة، نوبات ظهور أعراض مفاجئة، صداع مع عدم القدرة على تحمل الأضواء الساطعة، حمى و تيبس الرقبة.</p><p dir="RTL"><u>التأثيرات</u><u> </u><u>على</u><u> </u><u>المعدة</u><u> </u><u>و</u><u> </u><u>الجهاز</u><u> </u><u>الهضمي</u><u>:</u></p><p dir="RTL">إمساك، التهاب اللسان، تقرحات الفم، التهاب داخل الفم أو الشفاه، تغيرات في المذاق، اضطرابات في المعي السفلي (تتضمن التهاب القولون أو ازدياد حالة التهاب القولون التقرحي سوءاً أو مرض كرون)، التهاب البنكرياس.</p><p dir="RTL"><u>التأثيرات</u><u> </u><u>على</u><u> </u><u>الصدر</u><u> </u><u>أو</u><u> </u><u>الدم</u><u>:</u></p><p dir="RTL">ارتفاع ضغط الدم، انخفاض ضغط الدم (تتضمن الأعراض الإغماء، الشعور بالدوار أو الدوخة)، التهاب الأوعية الدموية، التهاب الرئة، اضطرابات قلبية، اضطرابات في الدم (تتضمن فقر دم).</p><p dir="RTL"><u>التأثيرات</u><u> </u><u>على</u><u> </u><u>الكبد</u><u> </u><u>أو</u><u> </u><u>الكلى</u><u>:</u></p><p dir="RTL">اضطرابات في الكلى أو اضطرابات حادة في الكبد تتضمن قصور في وظيفة الكبد، ظهور الدم أو البروتين في البول.</p><p dir="RTL"><u>التأثيرات</u><u> </u><u>على</u><u> </u><u>الجلد</u><u> </u><u>أو</u><u> </u><u>الشعر</u><u>:</u></p><p dir="RTL">تورم الوجه، طفح جلدي خطير يتضمن متلازمة ستيڤن-جونسون ومتلازمة ليل و أنواع أخرى من الطفح الجلدي التي قد تزداد سوءاً عند التعرض لأشعة الشمس.</p><p dir="RTL">فقدان الشعر.</p><p dir="RTL"><u>التأثيرات</u><u> </u><u>على</u><u> </u><u>الجهاز</u><u> </u><u>التناسلي</u><u>:</u></p><p dir="RTL">عجز جنسي.</p><p dir="RTL"><strong>تم</strong><strong> </strong><strong>تسجيل</strong><strong> </strong><strong>أيضا</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>ذات</strong><strong> </strong><strong>تكرار</strong><strong> </strong><strong>حدوث</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>معروف</strong><strong> </strong><strong>تتضمن</strong><strong>:</strong></p><p dir="RTL">اضطرابات في الحلق، ارتباك، هلوسات، الشعور بالتوعك (شعور عام&nbsp; بعدم الراحة)، التهاب الأعصاب في العين، اضطراب الإحساس.</p><p dir="RTL">قد ترتبط الأدوية مثل ديكلوفيناك بزيادة قليلة لخطر التعرض للنوبة القلبية أو السكتة الدماغية.</p><p dir="RTL">لا تقلق بشأن هذه القائمة حيث أن معظم الأشخاص الذين يتناولون<strong> </strong>أقراص <strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong><strong> </strong>بدون حدوث أي مشاكل.<strong>&nbsp;&nbsp; </strong></p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>حصل</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية،</strong><strong> </strong><strong>تحدث</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>. </strong><strong>هذا</strong><strong> </strong><strong>يشمل</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>مذكورة</strong><strong> </strong><strong>في</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>النشرة</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدا عن متناول الأطفال و نظرهم.</p><p dir="RTL">لا تستعمل<strong> </strong>هذا الدواء بعد تاريخ انتهاء الصلاحية (EXP) المذكورعلى الشريط و العلبة الخارجية.</p><p dir="RTL">تاريخ الانتهاء يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL"><strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;&nbsp; </sup></strong>أقراص: يحفظ&nbsp; بدرجة حرارة دون 30 &deg;م.</p><p dir="RTL">يجب أن لا يتم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير في حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي ديكلوفيناك بوتاسيوم.</p><p dir="RTL">المكونات الأخرى لاكتوز مونوهيدرات، جلايكولات نشا الصوديوم، نشا الذرة، ستيرات المغنيسيوم، تلك، أكسيد الحديد الأحمر، أوبادري OY-L أبيض (هيدروكسي بروبيل ميثيل سيليلوز/هيبروميلوز، ثاني أكسيد التيتانيوم، ماكروجول/بولي إيثيلين جلايكول)، بولي إيثيلين جلايكول، كوبوڤيدون، ميكروكريستالين سيليلوز.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>دولڤيك</strong><strong> - </strong><strong>ك</strong><strong><sup>&reg;</sup></strong><strong> 50 </strong><strong>ملغم</strong><strong>: </strong>أقراص مغلفة دائرية الشكل ذات لون بني محمر، محدبة الوجهين، لا تحتوي على خط للتقسيم، محفور على أحد الأوجه L12، معبأة في أشرطة بي ڤي سي/تي إي/بي ڤي دي سي/ألومنيوم، معدة للاستعمال عن طريق الفم.</p><p dir="RTL"><strong>حجم</strong><strong> </strong><strong>العبوة</strong>: 20 قرص مغلف (10 أقراص/شريط، 2 شريط/عبوة).</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مدينة الدواء للصناعات الدوائية - المملكة العربية السعودية.</p><p dir="RTL">المدينة الصناعية الأولى، المرحلة الخامسة، جدة- المملكة العربية السعودية.</p><p dir="RTL">الهاتف: 00966920003288&nbsp;</p><p dir="RTL">جوال: 00966555786968</p><p dir="RTL">ص.ب: 4072 &ndash; جدة 22429</p><p dir="RTL">البريد الإلكتروني: info@medcitypharma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             07/2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dolvic-K® 50 mg Film Coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains 50 mg of Diclofenac potassium.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets

Dolvic-K® 50 mg tablets are round, deep convex, reddish brown, non-scored film coated tablets engraved with L12 and plain on the other side, presented in PVC/TE/PVDC/Alu blisters, intended for oral use. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rheumatoid arthritis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Osteoarthrosis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low back pain.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Migraine attacks.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute musculo-skeletal disorders and trauma such as periarthritis (especially frozen shoulder), tendinitis, tenosynovitis, bursitis, sprains, strains and dislocations; relief of pain in fractures.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ankylosing spondylitis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute gout.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Control of pain and inflammation in orthopaedic, dental and other minor surgery.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pyrophosphate arthropathy and associated disorder</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4 Special warnings and precautions for use).</p><p>For oral administration</p><p>It is recommended that the tablets be taken with fluid, preferably with or after food.</p><p><strong>Adults</strong></p><p>The recommended daily dose is 100-150mg in two or three divided doses. For milder cases, 75-100 mg daily in two or three divided doses is usually sufficient.</p><p>In migraine an initial dose of 50 mg should be taken at the first signs of an impending attack. In cases where relief 2 hours after the first dose is not sufficient, a further dose of 50 mg may be taken. If needed, further doses of 50 mg may be taken at intervals of 4-6 hours, not exceeding a total dose of 200 mg per day.</p><p><strong>Special populations</strong></p><p><strong>Paediatrics</strong></p><p>For children over 14 years of age, the recommended daily dose is 75-100 mg in two or three divided doses. <strong>Dolvic-K<sup>&reg; </sup></strong>tablets are not recommended for children under 14 years of age. The use of <strong>Dolvic-K<sup>&reg; </sup></strong>(all forms) in migraine attacks has not been established in children.</p><p><strong>Elderly</strong></p><p>Although the pharmacokinetics of Diclofenac potassium are not impaired to any clinically relevant extent in elderly patients, nonsteroidal anti-inflammatory drugs should be used with particular caution in such patients who generally are more prone to adverse reactions. In particular it is recommended that the lowest effective dosage be used in frail elderly patients or those with a low body weight (see also precautions) and the patient should be monitored for GI bleeding during NSAID therapy.</p><p><strong>Cardiovascular and significant cardiovascular risk factors</strong></p><p>Diclofenac is contraindicated in patients with established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease (see section 4.3 Contraindications).</p><p>Patients with congestive heart failure (NYHA-I) or significant risk factors for cardiovascular disease should be treated with diclofenac only after careful consideration. Since cardiovascular risks with diclofenac may increase with dose and duration of exposure, the lowest effective daily dose should be used and for the shortest duration possible (see section 4.4 Special warnings and precautions for use).</p><p><strong>Renal impairment</strong></p><p><strong>Dolvic-K<sup>&reg; </sup></strong>is contraindicated in patients with renal failure (see section 4.3 Contraindications).&nbsp;</p><p><strong>&nbsp;</strong></p><p>No specific studies have been carried out in patients with renal impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering <strong>Dolvic-K<sup>&reg;</sup></strong> to patients with mild to moderate renal impairment (see section 4.4 Special warnings and precautions for use).</p><p><strong>Hepatic impairment</strong></p><p><strong>Dolvic-K<sup>&reg; </sup></strong>is contraindicated in patients with hepatic failure (see section 4.3 Contraindications).</p><p>No specific studies have been carried out in patients with hepatic impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering <strong>Dolvic-K<sup>&reg;</sup></strong> to patients with mild to moderate hepatic impairment (see section 4.4 Special warnings and precautions for use).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to the active substance or any of the excipients. 
• Active, gastric or intestinal ulcer, bleeding or perforation. 
• History of gastrointestinal bleeding or perforation, relating to previous NSAID therapy.
• Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
 • Last trimester of pregnancy (see section 4.6 Pregnancy and lactation).
 • Hepatic failure.
 • Renal failure.
 • Established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease.
 • Like other non-steroidal anti-inflammatory drugs (NSAIDs), diclofenac is also contraindicated in patients in whom attacks of asthma, angioedema, urticaria or acute rhinitis are precipitated by ibuprofen, acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2 Posology and method of administration and GI and cardiovascular risks below).</p><p>The concomitant use of <strong>Dolvic-K<sup>&reg; </sup></strong>with systemic NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided due to the absence of any evidence demonstrating synergistic benefits and the potential for additive undesirable effects (see section 4.5 Interactions with other medicaments and other forms of interaction).</p><p>Caution is indicated in the elderly on basic medical grounds. In particular, it is recommended that the lowest effective dose be used in frail elderly patients or those with a low body weight (see section 4.2 Posology and Method of administration).</p><p>As with other nonsteroidal anti-inflammatory drugs including diclofenac, allergic reactions, including anaphylactic/anaphylactoid reactions, can also occur without earlier exposure to the drug (see section 4.8 Undesirable effects). Hypersensitivity reactions can also progress to Kounis syndrome, a serious allergic reaction that can result in myocardial infarction.&nbsp; Presenting symptoms of such reactions can include chest pain occurring in association with an allergic reaction to diclofenac.</p><p>Like other NSAIDs, diclofenac may mask the signs and symptoms of the infection due to its pharmacodynamic properties.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Gastrointestinal effects:</strong></p><p>Gastrointestinal bleeding (haematemesis, melaena) ulceration or perforation which can be fatal has been reported with all NSAIDs including diclofenac and may occur at any time during treatment, with or without warning symptoms or a previous history of serious GI events. They generally have more serious consequences in the elderly. If gastrointestinal bleeding or ulceration occurs in patients receiving diclofenac, the drug should be withdrawn.</p><p>As with all NSAIDs, including diclofenac<strong>,&nbsp;</strong>close medical surveillance is imperative and particular caution should be excised when prescribing diclofenac in patients with symptoms indicative of gastrointestinal disorders, or with a history suggestive of gastric or intestinal ulceration, bleeding or&nbsp; perforation(see section 4.8 Undesirable effects).The risk of GI bleeding, ulceration or perforation is higher with &nbsp;increasing NSAID doses including diclofenac, and in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation.</p><p>The elderly have increased frequency of adverse reactions to NSAIDs especially gastro intestinal bleeding and perforation which may be fatal (see section 4.2 Posology and method of administration).</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation, and in the elderly, the treatment should be initiated and maintained at the lowest effective dose.</p><p>Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant use of medicinal products containing low dose acetylsalicylic acid (ASA/aspirin or medicinal products likely to increase gastrointestinal risk. (See section 4.5 Interactions with other medicaments and other forms of interaction).</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding).</p><p>Caution is recommended in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as systemic corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors (SSRIs) or anti-platelet agents such as acetylsalicylic acid (see section 4.5 Interaction with other medicaments and other forms of interaction).</p><p>Close medical surveillance and caution should be exercised in patients with ulcerative colitis, or with Crohn&#39;s disease as these conditions may be exacerbated (see section 4.8 Undesirable effects).</p><p>NSAIDs, including diclofenac, may be associated with increased risk of gastro-intestinal anastomotic leak.&nbsp; Close medical surveillance and caution are recommended when using diclofenac after gastro-intestinal surgery.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Hepatic effects:</strong></p><p>Close medical surveillance is required when prescribing Diclofenac potassium to patients with impairment of hepatic function as their condition may be exacerbated.</p><p>As with other NSAIDs, including diclofenac, values of one or more liver enzymes may increase. During prolonged treatment with Diclofenac, regular monitoring of hepatic function is indicated as a precautionary measure.</p><p>If abnormal liver function tests persist or worsen, clinical signs or symptoms consistent with liver disease develop or if other manifestations occur (eosinophilia, rash), <strong>Dolvic-K<sup>&reg; </sup></strong>should be discontinued.</p><p>Hepatitis may occur with diclofenac without prodromal symptoms.</p><p>Caution is called for when using diclofenac in patients with hepatic porphyria, since it may trigger an attack.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Renal effects:</strong></p><p>As fluid retention and oedema have been reported in association with NSAIDs therapy, including diclofenac, particular caution is called for in patients with impaired cardiac or renal function, history of hypertension, the elderly, patients receiving concomitant treatment with diuretics or medicinal products that can significantly impact renal function, and those patients with substantial extracellular volume depletion from any cause, e.g. before or after major surgery (see section 4.3 Contraindications). Monitoring of renal function is recommended as a precautionary measure when using diclofenac in such cases. Discontinuation therapy is usually followed by recovery to the pre-treatment state.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Skin effects:</strong></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including diclofenac potassium (see section 4.8 Undesirable effects). Patients appear to be at the highest risk of these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Diclofenac potassium should be discontinued at the first appearance of skin rash, mucosal lesions or any other signs of hypersensitivity.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>SLE and mixed connective tissue disease:</strong></p><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see section 4.8 Undesirable effects).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Cardiovascular and cerebrovascular effects:</strong></p><p>Patients with congestive heart failure (NYHA-I) or patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with diclofenac after careful consideration.</p><p>As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The pateint&rsquo;s need for symptomatic relief and response to therapy should be re-evaluated periodically.</p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and congestive heart failure (NYHA-I) as fluid retention and oedema have been reported in association with NSAID therapy, including diclofenac.</p><p>Clinical trial and epidemiological data consistently point towards increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150mg daily) and in long term treatment.</p><p>Patients should remain alert for the signs and symptoms of serious arteriothrombotic events (e.g. chest pain, shortness of breath, weakness, slurring of speech), which can occur without warnings. Patients should be instructed to see a physician immediately in case of such an event.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Haematological effects:</strong></p><p>Use of <strong>Dolvic-K<sup>&reg; </sup></strong>tablets 50mg are recommended only for short term treatment.</p><p>During prolonged treatment with diclofenac, as with other NSAIDs, monitoring of the blood count is recommended.</p><p>Diclofenac potassium may reversibly inhibit platelet aggregation (see anticoagulants in section 4.5 Interaction with other medicaments and other forms of interactions). Patients with defects of haemostasis, bleeding diathesis or haematological abnormalities should be carefully monitored.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Pre-existing asthma:</strong></p><p>In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma exacerbations (so called intolerance to analgesics / analgesics asthma), Quincke&rsquo;s oedema or urticaria are more frequent than in other patients. Therefore, special precaution is recommended in such patients (readiness for emergency). This is applicable as well for patients who are allergic to other substances, e.g. with skin reactions, pruritus or urticaria.</p><p>Like other drugs that inhibit prostaglandin synthetase activity, diclofenac sodium and other NSAIDs can precipitate bronchospasm if administered to patients suffering from, or with a previous history of bronchial asthma.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Female fertility:</strong></p><p>The use of Diclofenac potassium may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Diclofenac potassium should be considered (see section 4.6 Pregnancy and Lactation).</p><p><u>Excipient(s) of known effect</u></p><p>Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.&nbsp;</p><p><strong>&nbsp;</strong></p><p>This medicine contains less than 1mmol sodium (23mg) per tablet, that is to say essentially &#39;sodium free&#39;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with diclofenac gastro-resistant tablets and/or other pharmaceutical forms of diclofenac.</p><p><strong>Lithium:&nbsp;</strong>If used concomitantly, Diclofenac potassium may increase plasma concentrations of lithium. Monitoring of the serum lithium level is recommended.</p><p><strong>Digoxin:&nbsp;</strong>If used concomitantly, Diclofenac potassium may raise plasma concentrations of digoxin. Monitoring of the serum digoxin level is recommended.</p><p><strong>Diuretics and antihypertensive agents:&nbsp;</strong>Like other NSAIDs, concomitant use of Diclofenac potassium with diuretics and antihypertensive agents (e.g. beta-blockers, angiotensin converting enzyme (ACE) inhibitors may cause a decrease in their antihypertensive effect via inhibition of vasodilatory prostaglandin synthesis.</p><p>Therefore, the combination should be administered with caution and patients, especially the elderly, should have their blood pressure periodically monitored. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity (see section 4.4 Special warnings and precautions for use).</p><p><strong>Drugs known to cause hyperkalemia</strong>: Concomitant treatment with potassium-sparing diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium levels, which should therefore be monitored frequently (see section 4.4 Special warnings and precautions for use).</p><p><strong>Anticoagulants and anti-platelet agents:&nbsp;</strong>Caution is recommended since concomitant administration could increase the risk of bleeding (see section 4.4 Special warnings and precautions for use). Although clinical investigations do not appear to indicate that diclofenac has an influence on the effect of anticoagulants, there are reports of an increased risk of haemorrhage in patients receiving diclofenac and anticoagulant concomitantly (see section 4.4 Special warnings and precautions for use). Therefore, to be certain that no change in anticoagulant dosage is required, close monitoring of such patients is required. As with other nonsteroidal anti-inflammatory agents, diclofenac in a high dose can reversibly inhibit platelet aggregation.</p><p><strong>Other NSAIDs including cyclooxygenase-2 selective inhibitors and corticosteroids:&nbsp;</strong>Co- administration of diclofenac with other systemic NSAIDs or corticosteroids may increase the risk of gastrointestinal bleeding or ulceration. Avoid concomitant use of two or more NSAIDs (see section 4.4 Special warnings and precautions for use).</p><p><strong>Selective serotonin reuptake inhibitors (SSRIs):&nbsp;</strong>Concomitant administration of SSRI&rsquo;s may increase the risk of gastrointestinal bleeding (see section 4.4 Special warnings and precautions for use).</p><p><strong>Antidiabetics:&nbsp;</strong>Clinical studies have shown that Diclofenac potassium can be given together with oral antidiabetic agents without influencing their clinical effect. However there have been isolated reports of hypoglycaemic and hyperglycaemic effects necessitating changes in the dosage of the antidiabetic agents during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy.</p><p><strong>Methotrexate:&nbsp;</strong>Diclofenac can inhibit the tubular renal clearance of methotrexate hereby increasing methotrexate levels. Caution is recommended when NSAIDs, including diclofenac, are administered less than 24 hours before treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increase. Cases of serious toxicity have been reported when methotrexate and NSAIDs, including diclofenac are given within 24 hours of each other. This interaction is mediated through accumulation of methotrexate resulting from impairment of renal excretion in the presence of the NSAID.</p><p><strong>Ciclosporin:&nbsp;</strong>Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that would be used in patients not receiving ciclosporin.</p><p><strong>Tacrolimus:&nbsp;</strong>Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus. This might be mediated through renal antiprostagladin effects of both NSAID and calcineurin inhibitor.</p><p><strong>Quinolone antibacterials:&nbsp;</strong>Convulsions may occur due to an interaction between quinolones and NSAIDs. This may&nbsp;occur in patients with or without a previous&nbsp;history of epilepsy&nbsp;or convulsions.</p><p>Therefore, caution should be exercised when considering the use of a quinolone in patients who are already receiving an NSAID.</p><p><strong>Phenytoin:&nbsp;</strong>When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin.</p><p><strong>Colestipol and cholestyramine</strong>: These agents can induce a delay or decrease in absorption of diclofenac. Therefore, it is recommended to administer diclofenac at least one hour before or 4 to 6 hours after administration of colestipol/ cholestyramine.</p><p><strong>Cardiac glycosides:&nbsp;</strong>Concomitant use of cardiac glycosides and NSAIDs in patients may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.</p><p><strong>Mifepristone:&nbsp;</strong>NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.</p><p><strong>Potent CYP2C9 inhibitors:&nbsp;</strong>Caution is recommended when co-prescribing diclofenac with potent CYP2C9 inhibitors (such as voriconazole), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>Inhibition&nbsp; of&nbsp; prostaglandin&nbsp; synthesis&nbsp; may&nbsp; adversely&nbsp; affect&nbsp; the&nbsp; pregnancy&nbsp; and/or&nbsp; the&nbsp;&nbsp; embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and or cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1% up to approximately 1.5%.</p><p>The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has shown to result in increased pre-and post-implantation loss and embryo-foetal lethality.</p><p>In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during organogenetic period.</p><p>From the 20th week of pregnancy onward, Diclofenac potassium use may cause oligohydramnios resulting from foetal renal dysfunction. This may occur shortly after treatment initiation and is usually reversible upon discontinuation. In addition, there have been reports of ductus arterious constriction following treatment in the second trimester, most of which resolved after treatment cessation.&nbsp; Therefore, during the first and second trimester of pregnancy, Diclofenac potassium should not be given unless clearly necessary.&nbsp; If Diclofenac potassium is used by a woman attempting to conceive, or during the first or second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.&nbsp; Antenatal monitoring for oligohydramnios and ductus arteriosus constriction should be considered after exposure to diclofenac for several days from gestational week 20 onward. Diclofenac potassium should be discontinued if oligohydramnios or ductus arteriosus constriction is found.</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to:</p><p>-Cardiopulmonary toxicity (premature constriction/closure of the ductus arteriosus and pulmonary hypertension).</p><p>-Renal dysfunction (see above).</p><p>The mother and the neonate, at the end of the pregnancy, to:</p><p>- Possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses.</p><p>- Inhibition of uterine contractions resulting in delayed or prolonged labour</p><p>Consequently, Diclofenac potassium is contraindicated during the third trimester of pregnancy.</p><p><strong>Lactation</strong></p><p>Like other NSAIDs, diclofenac passes into breast milk in small amounts. , Therefore diclofenac should not be administered during breast feeding in order to avoid undesirable effects in the infant (see section 5.2 Pharmacokinetic properties).</p><p><strong>Female fertility</strong></p><p>As with other NSAIDs, the use of diclofenac may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of diclofenac should be considered.</p><p>See section 4.4 Special warnings and precautions for use, regarding female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:21.05pt; margin-right:20.7pt; text-align:left">Patients who experience visual disturbances, dizziness, vertigo, somnolence, central nervous system disturbances, drowsiness, or fatigue while taking NSAIDs should refrain from driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions are ranked under the heading of frequency, the most frequent first, using the following convention: very common: (&gt;1/10); common (&ge; 1/100, &lt;1/10); uncommon (&ge; 1/1,000, &lt;1/100); rare (&ge;1/10,000, &lt;1/1000); very rare (&lt;1/10,000); not known: cannot be estimated from available data.</p><p>The following undesirable effects include those reported with other short-term or long-term use.</p><p><strong>Table&nbsp;1</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Thrombocytopenia, leucopoenia, anaemia</p><p>&nbsp;(including haemolytic and aplastic</p><p>anaemia), agranulocytosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>Hypersensitivity, anaphylactic and</p><p>anaphylactoid reactions (including hypotension and shock).</p><p>&nbsp;</p><p>Angioneurotic oedema (including face oedema).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Disorientation, depression, insomnia,</p><p>Nightmare, irritability, psychotic disorder.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common Rare Very</p><p>&nbsp;</p><p>rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Unknown</p></td><td style="vertical-align:top"><p>Headache, dizziness. Somnolence, tiredness.</p><p>Paraesthesia, memory impairment, convulsion, anxiety, tremor, aseptic meningitis, taste disturbances, cerebrovascular accident.</p><p>Confusion, hallucinations, disturbances of sensation, malaise.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare Unknown</p></td><td style="vertical-align:top"><p>Visual disturbance, vision blurred diplopia. Optic neuritis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Vertigo.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Tinnitus, hearing impaired.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon*</p><p>&nbsp;</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>Myocardial infarction, cardiac failure, palpitations, chest pain.</p><p>&nbsp;</p><p>Kounis syndrome.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hypertension, hypotension, vasculitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare Very rare</p></td><td style="vertical-align:top"><p>Asthma (including dyspnoea). Pneumonitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td rowspan="2" style="vertical-align:top"><p>Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, Flatulence, anorexia.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>&nbsp;</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Gastritis, gastrointestinal haemorrhage, haematemesis, diarrhoea haemorrhagic, melaena, gastrointestinal ulcer with or without bleeding or perforation (sometimes fatal particularly in the elderly).</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Colitis (including haemorrhagic colitis and exacerbation of ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis (including ulcerative stomatitis), glossitis, oesophageal disorder, diaphragm-like intestinal strictures, pancreatitis.</p></td></tr><tr><td style="vertical-align:top"><p>Unknown</p></td><td style="vertical-align:top"><p>Ischaemic colitis</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Transaminases increased.</p><p>Hepatitis, jaundice, liver disorder.</p><p>Fulminant hepatitis, hepatic necrosis, hepatic failure.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Rash.</p><p>Urticaria.</p><p>Bullous eruptions, eczema, erythema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative, loss of hair, photosensitivity reaction, purpura, allergic purpura, pruritus.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Acute renal failure, haematuria, proteinuria, nephrotic syndrome, interstitial nephritis, renal papillary necrosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Impotence.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>General&nbsp;disorders and administration site conditions</strong></p><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Oedema</p></td></tr></tbody></table><p>&nbsp;* The frequency reflects data from long-term treatment with a high dose (150 mg/day).</p><p>Clinical trial and epidemiological data consistently point towards an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high doses (150mg daily) and in long term treatment (see sections 4.3 and 4.4 for Contraindications and Special warnings and special precautions for use).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms</strong></p><p>There is no typical clinical picture resulting from diclofenac over dosage. Over dosage can cause symptoms such as headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, diarrhoea, dizziness, disorientation, excitation, coma, drowsiness, tinnitus, fainting or convulsions. In the case of significant poisoning acute renal failure and liver damage are possible.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Therapeutic measures</strong></p><p>Management of acute poisoning with NSAIDs, including diclofenac, essentially consists of supportive measures and symptomatic treatment. Supportive measures and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastrointestinal disorder, and&nbsp;respiratory depression.</p><p>Special measures such as forced diuresis, dialysis or haemo-perfusion are probably of no help in eliminating NSAIDs, including diclofenac, due to high protein binding and extensive metabolism.</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and gastric decontamination (e.g. vomiting, gastric lavage) after ingestion of a potentially life threatening overdose</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group:&nbsp; Nonsteroidal anti-inflammatory drug (NSAID).</p><p>Anatomical Therapeutic Chemical (ATC) Code: M01AB05</p><p>Diclofenac potassium tablets contain the potassium salt of diclofenac, a nonsteroidal compound with pronounced and clinically demonstrable analgesic, anti-inflammatory and anti-pyretic properties.</p><p>Diclofenac is a potent inhibitor of prostaglandin bio-synthesis and modulator of arachidonic acid release and uptake.</p><p>Diclofenac potassium tablets have a rapid onset of action and are therefore suitable for the treatment of acute episodes of pain and inflammation.</p><p>In migraine attacks Diclofenac potassium has been shown to be effective in relieving the headache and in improving the accompanying symptom of nausea.</p><p>Diclofenac in vitro does not suppress proteoglycan biosynthesis in cartilage at concentrations equivalent&nbsp;to the concentrations reached in human beings.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption:</strong></p><p>Diclofenac is rapidly and completely absorbed from sugar-coated tablets. Food intake does not affect absorption.</p><p>Peak plasma concentration after one 50 mg sugar-coated tablet was 3.9 &micro;mol/l after 20-60 minutes. The plasma concentrations show a linear relationship to the size of the dose.</p><p>Diclofenac undergoes first-pass metabolism and is extensively metabolised.</p><p><strong>Distribution:</strong></p><p>Diclofenac is highly bound to plasma proteins (99.7%), chiefly albumin (99.4%).</p><p>Diclofenac was detected in a low concentration (100 ng/mL) in breast milk in one nursing mother. The estimated amount ingested by an infant consuming breast milk is equivalent to a 0.03 mg/kg/day dose (see section 4.6 Pregnancy and lactation).</p><p><strong>Elimination:</strong></p><p>The total systemic clearance of diclofenac in plasma is 263 &plusmn; 56 ml/min (mean &plusmn; SD). The terminal half-life in plasma is 1-2 hours.</p><p>Repeated oral administration of Diclofenac potassium for 8 days in daily doses of 50 mg t i d does not lead to accumulation of diclofenac in the plasma.</p><p>Approx. 60% of the dose administered is excreted in the urine in the form of metabolites, and less than 1% as unchanged substance. The remainder of the dose is eliminated as metabolites through the bile in the faeces.</p><p><strong>Biotransformation:</strong></p><p>The biotransformation of diclofenac involves partly glucuronidation of the intact molecule but mainly single and multiple hydroxylation followed by glucuronidation.</p><p><strong>Characteristics in patients:</strong></p><p>The age of the patient has no influence on the absorption, metabolism, or excretion of diclofenac.</p><p>In patients suffering from renal impairment, no accumulation of the unchanged active substance can be inferred from the single-dose kinetics when applying the usual dosage schedule. At a creatinine clearance of &lt;10 ml/min the theoretical steady-state plasma levels of metabolites are about four times higher than in normal subjects.&nbsp; However, the metabolites are ultimately cleared through the bile.</p><p>In the presence of impaired hepatic function (chronic hepatitis, non-decompensated cirrhosis) the kinetics and metabolism are the same as for patients without liver disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Relevant information on the safety of Diclofenac potassium is included in other sections of the Summary of Product Characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose monohydrate, sodium starch glycolate, maize starch, magnesium stearate, talc, red iron oxide, Opadry OY-L white (lactose monohydrate, HPMC/hypromellose, titanium dioxide, macrogol/PEC), polyethylene glycol, copovidone, and microcrystalline cellulose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Dolvic-K<sup>&reg; </sup>50 mg</strong> tablets are round, deep convex, reddish brown, non-scored film coated tablets engraved with L12 and plain on the other side, presented in PVC/TE/PVDC/Alu blisters, intended for oral use.</p><p><strong>Pack sizes: </strong>20 Film Coated Tablets (10 tablets/blister, 2 blisters/pack).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:14.35pt; margin-right:151.75pt; text-align:left; text-indent:-3.4pt">Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Med City Pharma-KSA.
1st Industrial city, Phase 5, Jeddah –KSA.
Tel: 00966920003288
Mobile: 00966555786968
P.O .Box: 4072 - Jeddah 22429
E-mail: info@medcitypharma.com


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07/2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>